GridAI Technologies (GRDX) Retained Earnings (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Retained Earnings came in at $239.7 million in Q2 2026, up 217.13% on a YoY basis from $75.6 million in Q2 2025, and up 4.88% quarter-over-quarter from $228.6 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Retained Earnings (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Retained Earnings for 12 consecutive years, with $239.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings rose 217.13% year-over-year to $239.7 million; the trailing twelve-month figure through Jun 2026 stood at $239.7 million (up 217.13% YoY), and the FY2025 full-year result was $228.6 million, up 212.93% from the prior year.
- Retained Earnings rose to $239.7 million in Q2 2026 per GRDX's latest filing, from $228.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at $239.7 million in Q2 2026 and bottomed at -$204.6 million in Q2 2025.
- Historically, Retained Earnings has averaged $63.2 million across 5 years, with a median of $177.7 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings plunged 240.1% in 2022, then soared 217.13% in 2026.
- Over 5 years, Retained Earnings stood at $171.3 million in 2022, then gained by 9.72% to $187.9 million in 2023, then slumped by 207.69% to -$202.4 million in 2024, then jumped by 212.93% to $228.6 million in 2025, then advanced by 4.88% to $239.7 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $239.7 million, $228.6 million, and $228.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | -22.28 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 9.53 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 15.69 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 37.62 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 558.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 20.97 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.13 Bn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 239.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239.71 Mn |
| Dec 31, 2025 | 228.56 Mn |
| Sep 30, 2025 | 228.39 Mn |
| Jun 30, 2025 | -204.65 Mn |
| Mar 31, 2025 | -203.65 Mn |
| Dec 31, 2024 | -202.39 Mn |
| Sep 30, 2024 | 198.52 Mn |
| Jun 30, 2024 | 196.69 Mn |
| Mar 31, 2024 | 194.94 Mn |
| Dec 31, 2023 | 187.93 Mn |
| Sep 30, 2023 | 183.51 Mn |
| Jun 30, 2023 | 177.68 Mn |
| Mar 31, 2023 | 175.32 Mn |
| Dec 31, 2022 | 171.28 Mn |
| Sep 30, 2022 | -164.55 Mn |
| Jun 30, 2022 | -168.94 Mn |
| Mar 31, 2022 | -163.53 Mn |
| Dec 31, 2021 | -153.90 Mn |
| Sep 30, 2021 | -142.73 Mn |
| Jun 30, 2021 | 120.58 Mn |